Advertisement
Singapore markets closed
  • Straits Times Index

    3,301.78
    +4.23 (+0.13%)
     
  • S&P 500

    5,483.24
    +10.01 (+0.18%)
     
  • Dow

    38,821.81
    +43.71 (+0.11%)
     
  • Nasdaq

    17,880.77
    +23.75 (+0.13%)
     
  • Bitcoin USD

    64,737.15
    -692.82 (-1.06%)
     
  • CMC Crypto 200

    1,352.07
    -37.33 (-2.69%)
     
  • FTSE 100

    8,187.29
    +45.14 (+0.55%)
     
  • Gold

    2,332.30
    +3.30 (+0.14%)
     
  • Crude Oil

    80.58
    +0.25 (+0.31%)
     
  • 10-Yr Bond

    4.2460
    -0.0330 (-0.77%)
     
  • Nikkei

    38,482.11
    +379.67 (+1.00%)
     
  • Hang Seng

    17,915.55
    -20.57 (-0.11%)
     
  • FTSE Bursa Malaysia

    1,606.13
    -1.19 (-0.07%)
     
  • Jakarta Composite Index

    6,734.83
    -96.73 (-1.42%)
     
  • PSE Index

    6,368.80
    -14.90 (-0.23%)
     

Inspire Medical Systems, Inc. to Present at the Truist Securities Medtech Conference

Inspire Medical Systems
Inspire Medical Systems

MINNEAPOLIS, June 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Truist Securities Medtech Conference on Tuesday, June 18, 2024.

Inspire is scheduled to present at 10:40 a.m. Eastern Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

ADVERTISEMENT

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443